Instrument Business Outlook Volume 31 - Issue 7

15 Jul 2022

Categories:

Instrument Business Outlook

Table of Contents

Scientific Tool Industry’s R&D Spending Continues a Steady Rise
- Sales & R&D Growth
- R&D as a Percentage of Sales
- Conclusion
Labs and Their Vendors Work to Make Labs More Sustainable
Executive Briefing
- Illumina Loses EU Referral Case
- Illumina Settles US BGI Litigation
- Meridian Bioscience Finds New Owner
- Chinese Life Science Consumables Supplier in Talks for Sale
- 10x Genomics’ Preliminary Results Show Sales Decline
- Azenta Reports Preliminary Revenues
- LGC Sells Drug Discovery Business
- Lab Automation Companies Recapitalize
First Quarter Results: 10x Genomics, HORIBA, Oxford Instruments, Pacific Biosciences and Sartorius
- 10x Genomics Faces Disruptions in Europe and China
- HORIBA Begins 2022 with Mixed Results
- Oxford Instruments Ends Fiscal 2022 with Strength
- Pacific Biosciences Experiences Sales Declines in Asia Pacific and Europe
- Sartorius' Bioanalytic Franchise Posts Solid Growth
Market Profile: Two-Dimensional LC (2D-LC)
- Leading Vendors
- Largest Markets
- Instrument Cost
Industry Watch
- Clinical
- Biopharma
- R&D
Region Watch
- Germany
- China
- France
News
- Sequencing
  - Company Announcements
  - Product Introductions
- Spectroscopy
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
- Surface Science
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
- Laboratory Products
  - Consumables
  - Company Announcements
  - Laboratory Automation
  - Company Announcements
  - New Products
  - Sales & Orders of Note
  - Sample Preparation
  - Product Introductions
  - Lab Equipment
  - Company Announcements
  - Product Introductions
Bottom Line

Attachments

IBO 071522 Issue.pdf